Method of treating chemical dependencies using sertraline
CA 2024181 C · Owner: Bick, Peter A. · Inventors: Bick, Peter A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
64680-569, Abstract, Disclosed is a medicine for treating a chemical dependency in a mammal in need of such treatment. The medicine contains an amount of the compound (IS-cis)-4-(3,4-dichlorophenyl)-1,2,3,4tetrahydro-N-methyl-l-naphthalenamine, also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof effective in reducing or alleviating such dependency in admixture, with a pharmaceutically acceptable carrier.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 28, 1990 and granted November 8, 1994. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 28, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 28, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.